CORRELATION OF HEAVY METAL LEVELS IN THE BLOOD OF PATIENTS WITH COLORECTAL CANCER WITH BIOLOGICAL FACTORS AND TREATMENT METHODS

CORRELATION OF HEAVY METAL LEVELS IN THE BLOOD OF PATIENTS WITH COLORECTAL CANCER WITH BIOLOGICAL FACTORS AND TREATMENT METHODS

The aim of the study. To evaluate the effect of radiation and chemotherapy treatment on the content of Cr, Cd, Cu, Pb, Zn in the blood of patients with colorectal cancer and to study the correlation between metal content and stage of CRC, sex, primary tumour location, blood type and rhesus factor. O...

Full description

Bibliographic Details
Main Authors:	Tataryn B. B., Kryzhanivska A. Ye., Ersteniuk H. M., Tataryn L. V.
Format:	Article
Language:	English
Published:	Ukrainian Medical Stomatological Academy 2020-12-01
Series:	Вісник проблем біології і медицини
Subjects:	colorectal cancer heavy metals radiation and chemotherapy treatment of colorectal cancer.
Online Access:	https://vpbm.com.ua/upload/2020-4(158)/42-min.pdf

Similar Items

Occupational Exposure to Heavy Metal Initiate Carcinogenesis Though BRAF/KRAS Over Expression and DNA Methylation
by: Ahmed Talaat Abd Elaziz, et al.
Published: (2020-05-01)

Essential Updates 2018/2019: Essential advances in surgical and adjuvant therapies for colorectal cancer
by: Tomonori Akagi, et al.
Published: (2020-01-01)

Quality of Life in Colorectal Cancer Outpatients
by: Cristiano Pereira de Oliveira, et al.
Published: (2018-08-01)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
by: Bengt Glimelius, et al.
Published: (2020-08-01)

Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the Literature
by: Chikako Funasaka, et al.
Published: (2019-08-01)

Current Treatments of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitors—2020 Update
by: Gerhard Jung, et al.
Published: (2020-10-01)

Molecular fundamentals of drug interactions in the therapy of colorectal cancer
by: Katarzyna Regulska, et al.
Published: (2014-03-01)

Molecular fundamentals of drug interactions in the therapy of colorectal cancer
by: Katarzyna Regulska, et al.
Published: (2014-03-01)

CLINICAL EXPERIENCE OF PROLONGED BEVACIZUMAB THERAPY IN METASTATIC COLORECTAL CANCER
by: I. S. Bulavina, et al.
Published: (2015-02-01)

CLINICAL EXPERIENCE OF PROLONGED AVASTIN THERAPY IN METASTATIC COLORECTAL CANCER
by: A. F. Saidullaeva
Published: (2015-02-01)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
by: Chen, Y., et al.
Published: (2022)

Advances in Bio-Based Polymers for Colorectal CancerTreatment: Hydrogels and Nanoplatforms
by: Anna Maspes, et al.
Published: (2021-01-01)

OXALIPLATIN/5-FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan N. Davidov
Published: (2013-12-01)

Diabetes Mellitus and Other Predictors for the Successful Treatment of Metastatic Colorectal Cancer: A Retrospective Study
by: Avram, V., et al.
Published: (2022)

Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as Biomarkers
by: Alexandra Gherman, et al.
Published: (2020-03-01)

The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program
by: Mark A. Healy, et al.
Published: (2018-04-01)

Long-Term Colon Stent Patency for Obstructing Colorectal Cancer Combined with Bevacizumab
by: Anouk E.J. Latenstein, et al.
Published: (2017-11-01)

Colorectal Cancer From Pathogenesis to Treatment
Published: (2016)

Superior Effect of the Combination of Carbon-Ion Beam Irradiation and 5-Fluorouracil on Colorectal Cancer Stem Cells in vitro and in vivo
by: Koom WS, et al.
Published: (2020-12-01)

Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study
by: Xicheng Wang, et al.
Published: (2017-10-01)

Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than Before, but How High Is It?
by: Erik Osterman, et al.
Published: (2020-11-01)

Genetic variants in p53 signaling pathway genes predict chemotherapy efficacy in colorectal cancer
by: Ke Zhang, et al.
Published: (2019-07-01)

FIVE-YEAR CANCER-SPECIFIC SURVIVAL OF STAGE III COLORECTAL CANCER PATIENTS
by: V. Т. Kokhnyuk
Published: (2015-02-01)

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
by: Min Shi, et al.
Published: (2020-03-01)

The Role of Intestinal Microbiota in Colorectal Cancer
by: Lingli Ren, et al.
Published: (2021-04-01)

Emergency treatment of complicated colorectal cancer
by: Tebala GD, et al.
Published: (2018-04-01)

Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer
by: Visvikis A, et al.
Published: (2020-02-01)

Targeting STAT3 Signaling Pathway in Colorectal Cancer
by: Antonios N. Gargalionis, et al.
Published: (2021-08-01)

Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer Center
by: Alexandros Georgiou, et al.
Published: (2019-10-01)

THE HIGH ACTIVITY OF VECTIBIX IN PATIENTS WITH METASTATIC COLORECTAL CANCER WITH THE RAS WILD-TYPE GENE
by: N. N. Semenov
Published: (2015-02-01)

Combined Effect of 5-Fluorouracil and Acriflavine on Mortality Rate of Colorectal Cancer Cell Lines
by: Parsa Zargar, et al.
Published: (2016-06-01)

Recommendations for the diagnosis and treatment of patients with colorectal cancer
by: Erik Brecelj, et al.
Published: (2020-11-01)

Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis
by: Sadayuki Kawai, et al.
Published: (2021-02-01)

Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study
by: Jinjia Chang, et al.
Published: (2019-01-01)

Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin
by: Giovanni Mauri, et al.
Published: (2021-05-01)

Early‐onset colorectal cancer in young individuals
by: Gianluca Mauri, et al.
Published: (2019-02-01)

INTEGRATION OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER CHEMOTHERAPY REGIMENS IN 2 CLINICAL CENTERS IN MOSCOW AND SAINT PETERSBURG
by: N. V. Dobrova, et al.
Published: (2015-02-01)

Pharmacoeconomic evaluation of the use of targeted therapy and chemotherapy in the first- and second-line therapies for metastatic colorectal cancer
by: A. A. Tryakin, et al.
Published: (2018-11-01)

Biweekly cetuximab and first-line chemotherapy in chinese patients with k-ras wild-type colorectal cancers
by: Wing-Lok Chan, et al.
Published: (2014-01-01)

BEVACIZUMAB COMBINED WITH IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN AS THE FIRST- LINE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA
by: Deyan Davidov
Published: (2014-12-01)